Gabelli & Co Investment Advisers’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-100,000	Closed	-$53.5K	–	295
2024 Q4	$53.5K	Buy	+100,000	New	+$69.7K	0.01%	212

Gabelli & Co Investment Advisers's MRNS Position: Q1 2025 in Review

Gabelli & Co Investment Advisers sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 100,000 shares — an estimated $53.5K sold.

Gabelli & Co Investment Advisers first reported a position in MRNS in Q4 2024 and held it in 1 quarter. The position peaked at $53.5K in Q4 2024. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

Gabelli & Co Investment Advisers reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 100,000 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $53.5K.
Gabelli & Co Investment Advisers first reported a position in Marinus Pharmaceuticals, Inc in Q4 2024 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Marinus Pharmaceuticals, Inc position peaked at $53.5K in Q4 2024.
0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2025, filed 14 May 2025.